div class=trans-pagebutton class=gotoPage data-page=1Page 1button div class=trans-imagea href=https:reader039fdocumentsecreader039viewer20220312065bc1dd3c09d3f27d2f8bce38html5page1jpg target=_blank img data-url=document-considerados-en-el-informe-presentado-por-el-sub-comite-de-homologacion-htmlpage=1 data-page=1 class=trans-thumb lazyload alt=Page 1: promesecalgobdopromesecalgobdowp-contentuploads201807Acta-de-Adjudicacion · considerados en el Informe presentado por el Sub-Comité de Homologación Lorazepam Multivitaminas loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader039fdocumentsecreader039viewer20220312065bc1dd3c09d3f27d2f8bce38html5thumbnails1jpg width=140 height=200 adivdivdiv class=trans-pagebutton class=gotoPage data-page=2Page 2button div class=trans-imagea href=https:reader039fdocumentsecreader039viewer20220312065bc1dd3c09d3f27d2f8bce38html5page2jpg target=_blank img data-url=document-considerados-en-el-informe-presentado-por-el-sub-comite-de-homologacion-htmlpage=2 data-page=2 class=trans-thumb lazyload alt=Page 2: promesecalgobdopromesecalgobdowp-contentuploads201807Acta-de-Adjudicacion · considerados en el Informe presentado por el Sub-Comité de Homologación Lorazepam Multivitaminas loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader039fdocumentsecreader039viewer20220312065bc1dd3c09d3f27d2f8bce38html5thumbnails2jpg width=140 height=200 adivdivdiv class=trans-pagebutton class=gotoPage data-page=3Page 3button div class=trans-imagea href=https:reader039fdocumentsecreader039viewer20220312065bc1dd3c09d3f27d2f8bce38html5page3jpg target=_blank img data-url=document-considerados-en-el-informe-presentado-por-el-sub-comite-de-homologacion-htmlpage=3 data-page=3 class=trans-thumb lazyload alt=Page 3:...